Skip to main content
Log in

Valproate encephalopathy and hypocarnitinaemia in diabetic patients

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Two patients with epilepsy and diabetes mellitus developed encephalopathy while on valproate monotherapy. Low plasma carnitine levels were found. Discontinuation of valproate was followed by clinical recovery and normalization of carnitine levels. Both valproate treatment and diabetes mellitus may contribute to secondary carnitine deficiency, with resultant encephalopathy. Thus, diabetic patients may be at increased risk of developing valproate encephalopathy associated with hypocarnitinaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bohan TP, Millington DS, Roe CR, et al (1984) Valproyl carnitine: a novel metabolite of valproic acid. Ann Neurol 16:39

    Google Scholar 

  2. Coulter DL (1991) Carnitine, valproate and toxicity. J Child Neurol 6:7–14

    Google Scholar 

  3. Dreifuss FE, Langer DH (1988) Side effects of valproate. Am J Med 84: [Suppl IA]:34–41

    Google Scholar 

  4. Jones GL, Matsuo F, Baringer JR, Reichert WH (1990) Valproic acid-associated encephalopathy. West J Med 153:199–202

    Google Scholar 

  5. Murakami K, Sugimoto T, Nishida N, et al (1992) Abnormal metabolism of carnitine and valproate in a case of acute encepbalopathy during chronic valproate therapy. Brain Dev 14:178–181

    Google Scholar 

  6. Ohtani Y, Endo F, Matsuda J (1982) Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 101:782–785

    Google Scholar 

  7. Schafer J, Reichmann H (1990) Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit. J Neurol 237:213–215

    Google Scholar 

  8. Triggs WJ, Bohan TP, Lin S-N, Willmore J (1990) Valproate-induced coma with ketosis and carnitine insufficiency. Arch Neurol 47:1131–1133

    Google Scholar 

  9. Trimble MR, Thompson PJ (1984) Sodium valproate and cognitive function. Epilepsia 25 [Suppl 1]:60–64

    Google Scholar 

  10. Verbiest HBC, Straver JS, Colombo JP, Vijver JCM van der, Woerkom TCAM van (1992) Carbamyl phosphate synthetase-1 deficiency discovered after valproic-acid induced coma. Acta Neurol Scand 86:275–279

    Google Scholar 

  11. Winter SC, Szabo-Aczel S, Curry J, et al (1987) Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child 141:660–665

    Google Scholar 

  12. Winter SC, Simon M, Zorn EM, et al (1989) Relative carnitine insufficiency in children with type I diabetes mellitus. Am J Dis Child 143:1337–1339

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Averbuch-Heller, L., Ben-Hur, T. & Reches, A. Valproate encephalopathy and hypocarnitinaemia in diabetic patients. J Neurol 241, 567–569 (1994). https://doi.org/10.1007/BF00873521

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00873521

Key words

Navigation